Memorial Sloan Kettering Cancer Center

New Capabilities

Co-led the research

For decades, cancer genetics meant finding mutations that raise risk. Now scientists have found one that lowers it. A variant in the MSI2 gene reduces the risk of blood cancers by up to 30% in people who carry two copies—the first protective genetic variant identified against myeloid malignancies.

Updated May 22